Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Teva Pharmaceutical Industries ADR
(NY:
TEVA
)
17.23
+0.12 (+0.73%)
Streaming Delayed Price
Updated: 10:01 AM EDT, Jul 12, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
431,218
Open
17.13
Bid (Size)
17.22 (6)
Ask (Size)
17.23 (5)
Prev. Close
17.10
Today's Range
17.07 - 17.23
52wk Range
7.950 - 17.69
Shares Outstanding
1,110,352,397
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Teva Pharmaceuticals Stock: Unlock Value in This Generic Drug Gem
July 10, 2024
Drug prices continue to rise, driving up healthcare costs. Pharmaceutical companies usually hike drug prices at the beginning of each year. In January 2024
Via
MarketBeat
Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024
July 02, 2024
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Performance
YTD
+61.43%
+61.43%
1 Month
-0.66%
-0.66%
3 Month
+24.19%
+24.19%
6 Month
+51.10%
+51.10%
1 Year
+113.44%
+113.44%
More News
Read More
FTC Crackdown on Teva Pharmaceuticals Over Inhaler Patent Abuse
July 01, 2024
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Dr. Reddy's Labs Stock Sees Improved Technical Strength
June 28, 2024
Via
Investor's Business Daily
Breaking Down Teva Pharmaceutical Indus: 5 Analysts Share Their Views
June 27, 2024
Via
Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today
June 12, 2024
Via
Benzinga
4 Analysts Assess Teva Pharmaceutical Indus: What You Need To Know
May 30, 2024
Via
Benzinga
New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses
June 28, 2024
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva Reaches Agreement With the Israel Tax Authority to Resolve All Pending Litigation for the Company's Taxable Years 2008-2020
June 25, 2024
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva Announces Launch of Authorized Generic of Victoza® (liraglutide injection 1.8mg), in the United States
June 24, 2024
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva Engages In Settlement Talks Over Medicare Kickback Allegations
June 18, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Teva Pharmaceutical Indus's Options Frenzy: What You Need to Know
May 22, 2024
Via
Benzinga
Concerpt Therapeutics Shares Are Trading Lower: What You Need To Know
June 14, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
7 A-Rated Biotech Stocks Worth Betting on in June
June 14, 2024
Via
InvestorPlace
What is a Bull Flag Pattern? Explanation and Examples
June 13, 2024
Via
MarketBeat
Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
June 04, 2024
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)
June 01, 2024
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024
June 01, 2024
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
2 Generic Drug Makers With Growing Runways
May 31, 2024
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day)
May 29, 2024
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
May 20, 2024
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
May 20, 2024
From
Alvotech
Via
GlobeNewswire
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
May 18, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade
May 16, 2024
Via
InvestorPlace
Topics
Intellectual Property
Exposures
Intellectual Property
Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations
May 15, 2024
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.